This section outlines scenarios in which the project’s infrastructure can make a significant impact, and are intended to guide the development of the project’s infrastructure and inform its priorities.
The Cancer Use Case has been the secondary use case to test the 1+MG Infrastructure. Although a work still in progress it has been acknowledged that the architecture largely supports the Cancer Use Case in its current format.
The Common and Complex Disease Use Case are focussing on the development of a national-focussed decision support software based on Polygenic Risk Scores (PRS) results.
The Genome of Europe project was created to have a Europe-wide collection of subgroup-specific reference genomes to support population genomics and make precision medicine more robust.